antabio logo
  • About Antabio
  • Programs
  • Our team
  • News
  • Jobs
  • Contact
Twitter

Gordon Waldron

Back to team members
Biography

Gordon has over 25 years’ experience in high tech, med tech and biotech. During his career, he has raised over €M140 in venture capital funding, over €M50 in an IPO and has been involved in 9 M&A transactions. Gordon is the Former Vice President and Chief Financial Officer of the antibacterial drug discovery company Novexel. At Novexel, he participated in a preclinical license negotiation which brought the company a €75 million upfront payment in 2008 and he negotiated the sale of Novexel to AstraZeneca for cash consideration of approximately €500 million in 2009.

Gordon Waldron, Antabio
Legal Notice | © copyright 2017 - Antabio - All rights reserved | Website by KWALT DIGITAL
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok